Oncolytics Biotech (Canada)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 45 papers

  • Open Access
  • Research Article
  • Citations1

Theranostic Potential of a New 64Cu-Labeled NOTA-R954 Peptide Conjugate for Kinin B1R Expressing Prostate Cancer

  • Sep 18, 2025
  • Pharmaceutics
  • Sadaf Ghanaatgar Kasbi +11
  • Research Article
  • Citations8

A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor–Positive Breast Cancer: The BRACELET-01/PrE0113 Study

  • Apr 29, 2025
  • Clinical Cancer Research
  • Amy S Clark +14
  • Open Access
  • Preprint Article

Single Versus Repeated Intravenous Oncolytic Virus Infusions – Implications for Rationalised Scheduling of Therapy in Hepatocellular Carcinoma

  • Sep 27, 2024
  • medRxiv
  • Karen J Scott +9
  • Research Article

Pelareorep driven blood TIL expansion in patients with pancreatic, breast and colon cancer.

  • Jun 01, 2024
  • Journal of Clinical Oncology
  • Richard Trauger +3
  • Research Article

Abstract B033: Multiplex analysis of the tumor immune microenvironment during treatment with atezolizumab/pelareorep/letrozole reveals novel immune-tumor interactions

  • Dec 01, 2023
  • Cancer Immunology Research
  • Homa Dadrastoussi +10
  • Open Access
  • Research Article
  • Citations6

1623P Pelareorep (pela) + atezolizumab (atezo) and chemotherapy in first-line (1L) advanced or metastatic pancreatic ductal adenocarcinoma (PDAC) patients: Results from the GOBLET study

  • Oct 01, 2023
  • Annals of Oncology
  • D Arnold +9
  • Research Article
  • Citations9

The differential expression of toll like receptors and RIG-1 correlates to the severity of infectious diseases

  • Jan 04, 2023
  • Annals of Diagnostic Pathology
  • Madison Rice +3
  • Conference Article

Perf Guns, They’re Not Just for Holes Anymore! Perf Cluster Tracer Injection

  • Sep 26, 2022
  • Christopher Squires +3
  • Research Article
  • Citations188

Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice.

  • Apr 13, 2022
  • Science Translational Medicine
  • Laura Evgin +20
  • Open Access
  • Research Article
  • Citations30

Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors

  • Jan 01, 2022
  • Neuro-oncology Advances
  • Matthew R Schuelke +9
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.